Calidi Biotherapeutics, Inc. agreed to sell Common Stock Units and Pre-Funded Warrant Units in a public offering for gross proceeds of approximately $6.077 million.
AI Assistant
CALIDI BIOTHERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.